merged_eu-covid-vaccines.txt
<question_number>1</question_number>
<answer>The ruling casts a shadow on Ursula von der Leyen before a crucial vote, giving momentum to her critics and potentially affecting her ability to secure a broad coalition of support.</answer>

<question_number>2</question_number>
<answer>Concerns about a lack of transparency in vaccine contracts under von der Leyen's leadership have contributed to distrust among European voters, which coincides with a recent surge in far-right politicians gaining seats.</answer>

<question_number>3</question_number>
<answer>The Greens, who are center-left lawmakers, have been incensed by her handling of the coronavirus crisis, making it more difficult for her to secure their support in the upcoming vote.</answer>

<question_number>4</question_number>
<answer>Concerns about transparency in vaccine contracts have contributed to distrust among voters, which coincides with the rise of far-right politicians in the European Parliament.</answer>

<question_number>5</question_number>
<answer>The ruling highlights concerns about transparency in vaccine contracts, which have contributed to voter distrust, coinciding with the rise of far-right politicians.</answer>

<question_number>6</question_number>
<answer>The ruling comes just ahead of a tight vote on von der Leyen’s future, potentially influencing the outcome by giving momentum to her critics.</answer>

<question_number>7</question_number>
<answer>The EU initially took a slow, budget-conscious approach but later secured a massive contract with Pfizer-BioNTech, leading to concerns about over-ordering and vaccine waste.</answer>

<question_number>8</question_number>
<answer>The European Commission claims it provided full information to the European Parliament, yet the court ruled that it wrongly withheld details of vaccine contracts.</answer>

<question_number>9</question_number>
<answer>The ruling reinforces the importance of freedom of information, which aligns with The New York Times' pending case seeking access to von der Leyen’s text messages with Pfizer’s CEO.</answer>

<question_number>10</question_number>
<answer>The ruling may reinforce public distrust in the EU’s handling of the pandemic, particularly regarding transparency, amid recent political shifts.</answer>